The unique reproductive concerns of young women with breast cancer.

Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Advances in experimental medicine and biology (Impact Factor: 1.83). 01/2012; 732:77-87. DOI: 10.1007/978-94-007-2492-1_6
Source: PubMed
  • [Show abstract] [Hide abstract]
    ABSTRACT: Assess fertility preservation (FP) measures chosen by patients newly diagnosed with malignancy and their outcomes. Reproductive-age patients referred for FP underwent counseling and elected cryopreservation vs. no treatment. Outcome measures included ovarian stimulation, FP choice, oocytes/zygotes retrieved/cryopreserved and pregnancy outcome. From 2005 to 2012, 136 patients were counseled with 124 electing treatment: 83 oocyte-only, 21 oocyte + zygote and 20 zygote-only cryopreservation. Age, partnership and financial status factored into FP choice. Treatment was completed in 12 ± 2 days with 14 ± 11 metaphase-II oocytes harvested and cryopreserved/cycle. Eight patients returned to attempt pregnancy; three succeeded. Our data demonstrate that oocyte and/or zygote banking are feasible FP options for women with malignancy; given the choice, the majority elected oocyte cryopreservation, highlighting desire for reproductive autonomy. Continued growth and research, combined with interdisciplinary communication, will ensure that appropriate candidates are offered FP and the potential for future parenthood, an important quality-of-life marker for survivors.
    Journal of Assisted Reproduction and Genetics 08/2013; · 1.82 Impact Factor